KRAS mutations in non-small-cell lung cancer and colorectal cancer: implications for EGFR-targeted therapies.
暂无分享,去创建一个
D. Gandara | H. Lenz | A. Hölscher | K. Danenberg | P. Mack | J. Brabender | P. Lara | M. Friedrich | P. Grimminger | H. Alakus | M. Maus | C. Stephens | S. Astrow | J. Hsiang | G. Zeger